BV

Babita Verma

Active Director Designated Partner DIN 09174153
DIN 09174153 First appointment May 2021 Primary industry Electrnoics
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Babita Verma

Data last updated:

Babita Verma is a Designated Partner at Medilyf Global Surgi Pharma Llp (since 2021). The company operates in Electrnoics.

DIN 09174153
Primary Designation Designated Partner
Industry Electrnoics
First Appointment 14 May 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner14 May 20212021Active

Board colleagues of Babita Verma

NameDINCompanyDesignation
Ojasvi Singh09174154Medilyf Global Surgi Pharma LlpDesignated Partner
Prashant Singh10380385Medilyf Global Surgi Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Medilyf Global Surgi Pharma Llp
Premium access

Shareholding and investment profile for Babita Verma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Babita Verma

Babita Verma currently holds 1 directorship: Medilyf Global Surgi Pharma Llp (Designated Partner, since 14 May 2021).

Babita Verma was first appointed on 14 May 2021 as Designated Partner at Medilyf Global Surgi Pharma Llp.

The current boards of Babita Verma's companies include Ojasvi Singh (Medilyf Global Surgi Pharma Llp), Prashant Singh (Medilyf Global Surgi Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available